Pharma giant Eli Lilly said it is negotiating to raise drug prices in Europe, starting in the U.K. with the weight-loss drug Mounjaro, so that it can comply with the Trump administration’s goal of bringing down prices in the U.S.

It comes as President Donald Trump pressures drugmakers to lower U.S. drug prices while hiking them abroad under a policy called "most favored nation."

As President Donald Trump works to move sky-high U.S. drug prices closer to those in other developed countries, Eli Lilly seems willing to play ball. | Eli Lilly said it has "intensified efforts to align prices across developed countries" in recent months.